Pathogenic germline variants in Mexican patients with hereditary breast and ovarian cancer syndrome

被引:0
|
作者
Vaca-Paniagua, Felipe
Quezada-Urban, Rosalia
Diaz-Velasquez, Clara
Gitler, Rina
Torres-Mejia, Gabriela
Rojo-Castillo, Maria Patricia
Sirota-Toporek, Max
Figueroa-Morales, Andrea
Moreno-Garcia, Oscar
Delgado-Enciso, Ivan
Garzon-Barrientos, Victor Hugo
Garcia-Esquivel, Nayeli Lizbeth
Rojas-Jimenez, Ernesto Arturo
Gregorio-Martinez, Hector
Terrazas, Luis Ignacio
机构
关键词
D O I
10.1158/1538-7445.AM2017-4275
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4275
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Germline pathogenic variants associated with ovarian cancer: A historical overview
    Johansen, Emma Lund
    Thusgaard, Christine Fribert
    Thomassen, Mads
    Boonen, Susanne Eriksen
    Jochumsen, Kirsten Marie
    [J]. GYNECOLOGIC ONCOLOGY REPORTS, 2022, 44
  • [32] Landscape of germline pathogenic variants in patients with dual primary breast and lung cancer
    Ning-Yuan Lee
    Melissa Hum
    Sabna Zihara
    Lanying Wang
    Matthew K. Myint
    Darren Wan-Teck Lim
    Chee-Keong Toh
    Anders Skanderup
    Jens Samol
    Min-Han Tan
    Peter Ang
    Soo-Chin Lee
    Eng-Huat Tan
    Gillianne G. Y. Lai
    Daniel S. W. Tan
    Yoon-Sim Yap
    Ann S. G. Lee
    [J]. Human Genomics, 17
  • [33] Identification of high and middle penetrance pathogenic variants in patients with hereditary breast/ovarian cancer by multigene panel analysis
    Ryu, Jin-Sun
    Cho, Eun Hae
    Yoon, Kyong-Ah
    Lee, Eun-Gyeong
    Lee, Eun-Sook
    Kong, Sun-Young
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [34] Comprehensive analysis of germline variants in patients with hereditary breast and ovarian cancer susceptibility from 4 countries of Latin America
    Vaca-Paniagua, Felipe
    Quezada-Urban, Rosalia
    Diaz Velasquez, Clara Estela
    Gomez Garcia, Eva Maria
    Mendez Catala, Claudia Fabiola
    Oliver, Javier
    Franco, Alejandra
    Frecha, Cecilia
    Riggi, Cecilia
    Carranza, Claudia
    Castaneda Altamirano, Carlos
    Milena Gomez, Ana
    Lorena Montealegre, Ana
    Gaitan Chaparro, Sandra
    Javier Lopez, Juan
    Perdomo, Sandra
    [J]. CANCER RESEARCH, 2019, 79 (13)
  • [35] Identification of germline pathogenic variants to guide systemic therapy: Prevalence and spectrum of PVs among Mexican patients with metastatic breast cancer
    Rodriguez-Olivares, Jose Luis
    Esparza-Orozco, Maria Fernanda
    Ramirez-Gonzalez, Jose Alfredo
    Sanchez-Reyes, Roberto Ivan
    Talamantes-Gamez, Enrique Isay
    Quintero-Beulo, Gregorio
    Lopez-Rosas, Gilberto
    Centelles-Lopez, Karla Alicia
    Moreno-Jaime, Brizio
    Vazquez-Juarez, Daniela
    Hernandez-Murillo, Ana Maria
    Tawil, Ilana de la Puente
    Weitzel, Jeffrey
    Garza, Cynthia Villareal
    Chavarri-Guerra, Yanin
    [J]. CANCER RESEARCH, 2024, 84 (09)
  • [36] Hereditary Breast and Ovarian Cancer Syndrome
    不详
    [J]. GYNECOLOGIC ONCOLOGY, 2009, 113 (01) : 6 - 11
  • [37] Hereditary Breast and Ovarian Cancer Syndrome
    Modesitt, Susan C.
    Lu, Karen
    Chen, Lee-May
    Powell, C. Bethan
    [J]. OBSTETRICS AND GYNECOLOGY, 2017, 130 (03): : E110 - E126
  • [38] Hereditary breast and ovarian cancer syndrome
    Tamaki, Yasuhiro
    [J]. CANCER SCIENCE, 2018, 109 : 778 - 778
  • [39] Impact of germline variants in cancer susceptibility genes in sardinian patients with breast and ovarian cancer
    Lorrai, Michela
    Tranquilli, Stefania
    Mereu, Caterina
    Mocci, Stefano
    Cannas, Federica
    Mascia, Alessia
    Sanna, Celeste
    Bucca, Alessia
    Zoboli, Laura Ghelfi
    Lai, Francesco
    Mancuso, Giancarlo
    Marongiu, Federico
    Mura, Michela
    Balestrino, Luisa
    Spina, Francesca
    Vivanet, Caterina
    Orru, Nicola
    Giuressi, Erika
    Giglio, Sabrina
    [J]. EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 561 - 562
  • [40] Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer
    Megid, Thais Baccili Cury
    Barros-Filho, Mateus C. C.
    Pisani, Janina Pontes
    Achatz, Maria Isabel
    [J]. FRONTIERS IN ONCOLOGY, 2022, 12